Overview

Fenofibrate in Combination With Ursodeoxycholic Acid in Primary Biliary Cholangitis

Status:
Recruiting
Trial end date:
2025-12-31
Target enrollment:
Participant gender:
Summary
The main objectives of the study were to assess the effects of fenofibrate on serum alkaline phosphatase, as a composite endpoint and on safety in participants with primary biliary cholangitis (PBC)
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Han Ying
Treatments:
Fenofibrate